Q2 EPS Estimate for Abeona Therapeutics Lowered by Analyst
Abeona Therapeutics Inc (NASDAQ:ABEO – Free Report) – Equities researchers at HC Wainwright dropped their Q2 2025 earnings per share (EPS) estimates for Abeona Therapeutics in a research report issued to clients and investors on Wednesday, April 30th. HC Wainwright analyst R. Selvaraju now forecasts that the biopharmaceutical company will post earnings per share of […]
